By BO LEUNG in London | CHINA DAILY | Updated: 2021-05-10 07:02 Share CLOSE A health worker checks a woman who received a dose of the China-made Sinopharm COVID-19 vaccine in Panadura, a suburb of Sri Lanka s capital, Colombo, on Saturday. ISHARA S. KODIKARA/AFP
The World Health Organization s approval to give emergency use to the COVID-19 vaccine manufactured by China s Sinopharm has been welcomed by experts and health regulators worldwide.
On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to be rolled out globally to reach countries in need and boost WHO-backed efforts such as the COVAX initiative.
A health worker checks a woman who received a dose of the China-made Sinopharm COVID-19 vaccine in Panadura, a suburb of Sri Lanka s capital, Colombo, on Saturday. ISHARA S. KODIKARA/AFP
BEIJING/LONDON, May 10 (China Daily/ANN): The World Health Organization s approval to give emergency use to the COVID-19 vaccine manufactured by China s Sinopharm has been welcomed by experts and health regulators worldwide.
On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to be rolled out globally to reach countries in need and boost WHO-backed efforts such as the COVAX initiative.
An international medical journal has called on the Narendra Modi government to own up mistakes, provide responsible leadership and implement a science-based response to steer India out of its Covid-19 crisis and “botched vaccination campaign”, describing some of its actions as “inexcusable”.
Soon after the call from The Lancet journal, the Indian Medical Association (IMA), the country’s largest body of doctors, accused the Modi government of inappropriate actions, hiding data and deaths and failing to plan a roadmap to ensure adequate vaccines were available.
The Lancet, in a commentary on Friday on India’s Covid-19 emergency, cited how the government had allowed religious festivals to proceed, along with huge political rallies, conspicuous for their lack of Covid-19 mitigation measures, despite warnings about the risks of super-spreader events.
W.H.O. approves Chinaâs Sinopharm vaccine for emergency use.
Video
-0:00
W.H.O. Approves Chinaâs Sinopharm Covid-19 Vaccine
The World Health Organizationâs authorization of the vaccine for emergency use on Friday allows it to be included in Covax, W.H.Oâs global initiative to increase vaccine access in low- and middle-income countries.
Solving the vaccine crisis requires that we pull out all the stops. W.H.O. is continuing to explore every avenue for increasing access to vaccines globally. This afternoon, W.H.O. gave emergency-use listing to Sinopharm, Beijingâs Covid-19 vaccine, making it the sixth vaccine to receive W.H.O. validation for safety, efficacy and quality. This expands the list of vaccines that Covax can buy, and gives countries confidence to expedite their own regulatory approval and to import and administer a vaccine. The strategic advisory group of experts on immunization, or SAGE, has also reviewed the available data and recommends the v
Covid-19 Live Updates: W H O Approves China s Sinopharm Vaccine nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.